全球動物用藥品市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計獸用治療市場將從 2025 年的 578.6 億美元成長到 2034 年的 1,014.7 億美元，2026 年至 2034 年的複合年成長率為 6.44%。

全球獸藥市場持續成長，主要得益於人們對動物健康和福利日益成長的關注。寵物飼養量的增加、畜牧業的擴張以及預防和治療動物疾病需求的不斷成長，都推動了獸藥及治療方法的需求。獸藥包括疫苗、感染疾病物、驅蟲藥以及其他旨在改善動物健康的藥物。隨著動物醫療保健體系的日益完善，無論是在已開發地區還是開發中國家地區，最新獸藥治療方法的應用都在顯著增加。

市場成長受多種因素驅動，包括動物疾病的蔓延、人們對通用感染疾病的認知不斷提高，以及確保畜牧業食品安全的需求。各國政府和農業組織正在推廣動物健康計劃，以預防疾病爆發並提高生產力。此外，藥物研發和診斷技術的進步也使得治療更加有效。寵物飼主越來越願意在先進的獸醫護理上投入資金，這也促進了市場擴張。

未來，隨著研發過程中新治療方法的不斷湧現，獸醫市場預計將進一步擴張。生物技術和精準醫療將在動物標靶治療的研發中發揮越來越重要的作用。包括遠端監測和遠端獸醫服務在內的數位健康技術也有望提升獸醫服務的品質。隨著全球對動物性食品需求的成長以及寵物飼養量的持續上升，獸醫市場預計將保持強勁成長動能。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球動物用藥品市場：依產品類型分類

• 市場分析、洞察與預測
• 製藥
• 疫苗
• 藥用飼料添加劑

第5章 全球動物用藥品市場：依動物類型分類

• 市場分析、洞察與預測
• 伴侶
• 家畜

第6章 全球動物用藥品市場：依給藥途徑分類

• 市場分析、洞察與預測
• 口服
• 腸外
• 外用

第7章 全球動物用藥品市場：依通路分類

• 市場分析、洞察與預測
• 動物醫院
• 動物診所
• 藥局和藥局
• 其他

第8章：全球動物用藥品市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Zoetis
  • Intervet Inc.（Merck Animal Health）
  • Elanco
  • Merial
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Vetoquinol SA
  • IDEXX Laboratories Inc
  • Virbac

The Veterinary Therapeutics Market size is expected to reach USD 101.47 Billion in 2034 from USD 57.86 Billion (2025) growing at a CAGR of 6.44% during 2026-2034.

The global veterinary therapeutics market has grown steadily due to increasing attention to animal health and welfare. Rising pet ownership, expanding livestock industries, and the growing need to prevent and treat animal diseases have fueled demand for veterinary medicines and treatments. Veterinary therapeutics include vaccines, anti-infectives, parasiticides, and other pharmaceutical products designed to improve animal health. As animal healthcare systems become more advanced, the adoption of modern veterinary treatments has increased significantly across both developed and developing regions.

Market growth is driven by several factors, including the rising prevalence of animal diseases, the growing awareness of zoonotic diseases, and the need to ensure food safety in livestock production. Governments and agricultural organizations are promoting animal health programs to prevent disease outbreaks and improve productivity. Additionally, technological advancements in drug development and diagnostics are enabling more effective treatments. The increasing willingness of pet owners to spend on advanced veterinary care is also contributing to market expansion.

In the future, the veterinary therapeutics market is expected to expand further as research and innovation lead to new treatment options. Biotechnology and precision medicine are likely to play a larger role in developing targeted therapies for animals. Digital health technologies, including remote monitoring and tele-veterinary services, may also enhance veterinary care. As global demand for animal-derived food products rises and pet ownership continues to grow, the market for veterinary therapeutics will remain strong.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Drugs
• Vaccines
• Medicated Feed Additives

By Animal Type

• Companion
• Livestock

By Route of Administration

• Oral
• Parenteral
• Topical

By Distribution Channels

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores
• Others

COMPANIES PROFILED

• Zoetis, Intervet Inc Merck Animal Health, Elanco, Merial, Bayer AG, Boehringer Ingelheim International GmbH, Ceva, Vetoquinol SA, IDEXX Laboratories Inc, Virbac
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY THERAPEUTICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Medicated Feed Additives Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY THERAPEUTICS MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Animal Type
• 5.2. Companion Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Livestock Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY THERAPEUTICS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Route Of Administration
• 6.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Parenteral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY THERAPEUTICS MARKET: BY DISTRIBUTION CHANNELS 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channels
• 7.2. Veterinary Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Veterinary Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Pharmacies & Drug Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY THERAPEUTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Animal Type
  • 8.2.3 By Route Of Administration
  • 8.2.4 By Distribution Channels
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Animal Type
  • 8.3.3 By Route Of Administration
  • 8.3.4 By Distribution Channels
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Animal Type
  • 8.4.3 By Route Of Administration
  • 8.4.4 By Distribution Channels
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Animal Type
  • 8.5.3 By Route Of Administration
  • 8.5.4 By Distribution Channels
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Animal Type
  • 8.6.3 By Route Of Administration
  • 8.6.4 By Distribution Channels
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL VETERINARY THERAPEUTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Zoetis
  • 10.2.2 Intervet Inc. (Merck Animal Health)
  • 10.2.3 Elanco
  • 10.2.4 Merial
  • 10.2.5 Bayer AG
  • 10.2.6 Boehringer Ingelheim International GmbH
  • 10.2.7 Ceva
  • 10.2.8 Vetoquinol S.A
  • 10.2.9 IDEXX Laboratories Inc
  • 10.2.10 Virbac